A comment on a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia by Zhou et al
dc.authorid | Demirci, Ufuk/0000-0001-6923-1470 | |
dc.contributor.author | Demirci, Ufuk | |
dc.contributor.author | Umit, Elif G. | |
dc.contributor.author | Demir, Ahmet Muzaffer | |
dc.date.accessioned | 2024-06-12T11:20:15Z | |
dc.date.available | 2024-06-12T11:20:15Z | |
dc.date.issued | 2020 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.doi | 10.1002/ajh.25740 | |
dc.identifier.endpage | E104 | en_US |
dc.identifier.issn | 0361-8609 | |
dc.identifier.issn | 1096-8652 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 31957064 | en_US |
dc.identifier.scopus | 2-s2.0-85079005953 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | E103 | en_US |
dc.identifier.uri | https://doi.org/10.1002/ajh.25740 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/25515 | |
dc.identifier.volume | 95 | en_US |
dc.identifier.wos | WOS:000510684700001 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | American Journal Of Hematology | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | A comment on a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia by Zhou et al | en_US |
dc.type | Letter | en_US |